Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03668340
Title AZD1775 in Women With Recurrent or Persistent Uterine Serous Carcinoma or Uterine Carcinosarcoma
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements Yes
Sponsors Dana-Farber Cancer Institute
Indications

endometrial serous adenocarcinoma

uterine carcinosarcoma

Therapies

Adavosertib

Age Groups: adult | senior
Covered Countries USA

Additional content available in CKB BOOST